Spontaneous spinal epidural hematoma in the setting of Evans syndrome: a case report and literature review Authors: William Ross Taylor, Andrew Kirk, Christopher Matthew Meuth, Carter Cassidy, Parker Prusick Published: 2026 ABSTRACT BackgroundSpontaneous spinal epidural hematoma (SSEH) is a rare condition with potential for devastating neurologic outcomes. The etiology of SSEH is not well understood. However, it has been linked with blood dyscrasias and anticoagulant administration. The treatment for SSEH is dependent upon patient presentation and consists of surgical decompression or close observation and treatment of any underlying coagulopathy. In cases where there is progressive or severe neurologic deficit, time to decompression has been shown to influence patient outcomes. Immune thrombocytopenia (ITP) is an autoimmune hematologic disorder resulting in decreased production and altered function of platelets. Evans syndrome (ES) is a rare variant of ITP diagnosed in <5% of ITP cases. Platelet counts of less than 30,000 have been associated with increased risk of bleeding events in those with ITP. Skin, oral, and nasal mucosal surfaces are the most common locations of spontaneous bleeding. The central nervous system accounts for less than 1% of spontaneous bleeds. To our knowledge, this is the first reported case of SSEH in a patient with ES.Case DescriptionIn the case at hand, a 69-year-old male patient with ES presented with acute, severe, atraumatic pain in the lower cervical region. His examination did not reveal neurologic deficit. Advanced imaging demonstrated a large epidural hematoma in the cervicothoracic region with mass effect on the adjacent spinal cord. The patient underwent urgent surgical decompression without complication along with medical treatment of his thrombocytopenia. Postoperatively, his neurologic status remained preserved without any other known bleeding events. He currently receives immunotherapy for ES management.ConclusionsSSEH is a rare pathology that can result in catastrophic neurologic injury. There are only a few previously reported cases of SSEH in the setting of ITP. In this instance, initial treatment is dependent upon patient presentation, followed by appropriate workup/management of the underlying blood dyscrasia. Highlight box Key findings • Spontaneous spinal epidural hematoma (SSEH) is a rare pathology with potentially catastrophic consequences. Management is dependent upon initial presentation and timing of symptoms. What is known and what is new? • SSEH can be treated with surgical intervention or via supportive measures with close observation. • In this case, a rare blood dyscrasia that had not been optimally treated was associated with SSEH. What is the implication and what should change now? • Treatment of SSEH is highly dependent upon patient presentation. In the setting of an untreated blood dyscrasia, it may not be unreasonable to lower the threshold for proceeding to the operating room for decompression. Introduction Spontaneous spinal epidural hematoma (SSEH) is a rare condition that can result in potentially catastrophic and debilitating neurologic injury. The incidence of SSEH is estimated to be approximately 0.1 per 100,000 per year and can occur at any level but has a predilection for the cervicothoracic and thoracolumbar regions (1). Presentation is highly variable, and the underlying mechanism by which the lesion occurs is debated (2,3). In one of the largest reviews to date, 104 of 613 patients who experienced SSEH had either an acquired/congenital hemorrhagic diathesis or were considered to have an iatrogenic coagulopathy from anticoagulation administration (3). Evans syndrome (ES) is a rare autoimmune disorder, first described in 1951, characterized by autoimmune hemolytic anemia and immune thrombocytopenia (ITP) with or without immune neutropenia that occurs in the absence of an underlying cause. It is diagnosed in less than 5% of ITP cases and has been linked to cases of life-threatening spontaneous hemorrhage (4). The purpose of this report is to describe a case of spontaneous epidural hematoma in a patient with ES and to review and discuss the relevant literature. We present this article in accordance with the CARE reporting checklist (available at https://jss.amegroups.com/article/view/10.21037/jss-2026-1-0031/rc). Case presentation A 69-year-old male with hypertension, ES, and chronic corticosteroid use presented as a transfer from an outside hospital (OSH) following the development of atraumatic, severe cervicothoracic back pain and reported intermittent right lower and upper extremity radicular symptoms roughly 24 hours prior. Computed tomography (CT) scans obtained at OSH were concerning for a mass-occupying lesion in the cervicothoracic spine. The patient was transferred to our tertiary center for further evaluation and to obtain emergent magnetic resonance imaging (MRI). All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee(s) and with the Declaration of Helsinki and its subsequent amendments. Publication of this case report and accompanying images was waived from patient consent according to the University of Kentucky ethics committee. At initial examination, the patient had intact strength and sensation in bilateral upper and lower extremities. Patellar reflexes were 3+ bilaterally. He was unable to urinate, which prompted placement of a foley catheter with return of over 800 mL of urine. Initial lab work was notable for platelet count of 20,000/µL (reference range: 155–369,000/µL), prothrombin time 14.5 s (reference range: 12–14.3 s), INR 1.1, and APTT 22 s (reference range: 25–35 s). MRI obtained shortly after presentation demonstrated a mass occupying lesion extending from C4–T1 that was hypointense on T1 series and intermediate intensity on T2 series, consistent with hematoma, causing severe stenosis from C6–T1 (Figure 1). T1 (A) and T2 (B) weighted images of the cervical spine demonstrating a mass occupying lesion in the dorsal epidural space from C4–T1 with maximum stenosis at the level of C7. The lesion appears hypointense on T1-weighted sequence and intermediate intensity on T2-weighted sequence. Given his acute and progressive pain, severity of stenosis seen on MRI, 3/4 patellar reflexes, and inability to micturate, there was concern that he was demonstrating signs of myelopathy and that spinal cord infarction and neurologic compromise could be impending. Surgical decompression as well as nonoperative management, along with their respective risks and benefits, were discussed with the patient and his family. It was mentioned that operative intervention could fail to adequately decompress the lesion or result in further hemorrhage that could compress the spinal cord and result in potentially permanent neurologic injury. The patient elected to proceed to the operating room (OR) for decompression. Utilizing a posterior approach, right C6 and C7 hemilaminectomies and bilateral T1 laminotomies were performed. There was an extensive epidural hematoma spanning these segments, contributing to severe stenosis. Following evacuation, a healthy pulsation was noted to return to the thecal sac. No tumor-like mass or obvious vascular malformations were observed. Prior to closure, a significant portion of the case was spent controlling bleeding from the bone surfaces and epidural veins. Hemostasis was maintained with a combination of bone wax, oxidized regenerated cellulose, and bipolar electrocautery. A subfascial drain was placed and the wound was closed in layered fashion. Two units of platelets were transfused in the OR. There were no neuromonitoring changes during the case. Postoperatively, the patient was admitted to the medical intensive care unit (MICU) as he initially required a nicardipine drip to maintain normotension. The patient experienced improvement in his severe, radiating neck and extremity pain and demonstrated an intact neurologic examination. Postoperative upright radiographs were obtained. The hematology service was consulted and the patient’s home dose of prednisone was restarted (10 mg/day). He was downgraded to the floor on postoperative day 2. At that time, his drain was removed. One unit of platelets was transfused on postoperative days 3 and 4 to maintain a platelet goal >50,000/µL. On postoperative days 4 and 5, the patient received intravenous immunoglobulin (IVIG) (1 g/kg/day). The patient was discharged on postoperative day 5. At his 2-week postoperative follow-up, he was noted to have full strength and sensation in bilateral upper and lower extremities without the presence of pathologic reflexes. His surgical wound was well healed. Upright radiographs did not show change in coronal or sagittal balance. He had established care with a hematologist at our institution for further workup and management of his thrombocytopenia. At his most recent follow-up, 5 months postoperatively, he had preserved motor and sensory function and reported no new bleeding events. Discussion The mechanism by which spinal epidural hemorrhage occurs has previously been debated. One theory suggests that bleeding results from rupture of valveless epidural veins after an episode of increased intra-abdominal pressure that could result from an activity of daily living such as sneezing or defecation. Another theory postulates that the source of bleeding is arterial in nature, which is supported by rapid onset of symptoms and the fact that intrathecal pressures are typically greater than those of the epidural venous plexus (5,6). Hypertension, which had previously been described as a risk factor for SSEH, was found by both Bakker and Groen to occur at comparable rates between those who experienced SSEH and the general population (1,7). Vascular malformation has been noted as a risk factor in patients who experience tumor hemorrhage, receive anticoagulation therapy or experience traumatic vertebral fracture (3). The onset of SSEH can range from minutes to weeks. Symptoms classically manifest with initial back/neck pain in the associated region. However, there may also be concomitant cerebral symptoms such as headache, oculomotor findings and seizure (3). Acuity and magnitude of the underlying hemorrhage and the patient’s ability to compensate dictate symptom progression. Cases of acute catastrophic hemorrhage may result in rapid paralysis/sensory deficits, including loss of bladder and bowel function, below the level of the lesion. Whereas subacute cases may result in waxing and waning pain with or without insidious progression of neurologic deficit/development of myelopathic symptoms (1,3,5). In the case at hand, the patient presented with a hallmark historical finding of SSEH, intense back pain around the level of the lesion. However, this symptom was accompanied by the onset of bladder dysfunction despite no identifiable motor deficits in the extremities. In their review of 613 cases of spinal hematoma, Kreppel et al. found that bowel/bladder dysfunction in the acute phase was always accompanied by either complete paralysis or partial motor/sensory deficits (3). Prolonged supine positioning and increased levels of pain could have contributed to new onset urinary retention in this case (8). However, sphincter dysfunction as a manifestation of myelopathy in the setting of an uncontrolled epidural lesion could not be excluded. In cases of SSEH, treatment is largely dictated by presentation. The treatment of choice for patients presenting with new and or progressing neurologic deficit is emergent surgical decompression (5). Inadequate decompression or bleeding from cancellous bone that cannot be controlled may result in the need to return to the OR. Decompression may need to be accompanied by posterior spinal fusion in order to decrease the chance of future spinal deformity (9). In pediatric populations, patients with subacute/chronic presentation, improving symptoms, or those who are not surgical candidates, conservative measures may be trialed. Conservative measures may include administration of steroids, correction of coagulopathy, strict bed rest, observation alone, or a combination thereof (5,10,11). Although there has been investigation into predictors of patient outcomes, prospective studies are needed in order to compare surgical versus conservative management in patients who present with mild or non-acute symptoms. Multiple studies have documented the importance of neurologic status upon presentation as a prognostic factor in SSEH (1,3,10,12). In their review of 17 cases of SSEH, Rajz et al. found that 8 out of 9 patients who presented with American Spinal Injury Association (ASIA) C or D impairment levels improved to ASIA level E (one ASIA C patient improved to level D) whereas 5 out of 8 patients who presented as ASIA A status did not show functional improvement following emergent surgical decompression (12). In Kreppel’s review of 613 cases, 33 patients were treated conservatively. Of those 33 patients, 25 were documented to have complete recovery. Although neither ASIA level nor Frankel score was assigned in their study, the majority of the conservatively managed patients were reported to have presented with incomplete/mild paralysis or cerebral symptoms that were acute/subacute in chronicity (3). In Groen’s 2004 review comparing conservative versus operative management, 84% of conservatively managed patients had complete neurologic recovery. However, the severity of presenting symptoms in the conservatively managed group was found to be significantly decreased compared to patients managed operatively (13). Time to intervention has also been found to be associated with patient outcomes. Surgical decompression within 12–24 hours of symptom onset has been shown to result in greater chances of improved clinical outcomes, especially when presenting deficits are moderate to severe or show sign of progression (1,3,10,14,15). When the presenting symptoms are mild or subacute and there is an absence of deficit progression, the time to intervention may not be as crucial as evidenced by one study in which nearly 70% of patients who underwent decompression greater than one week following the onset of symptoms had good outcomes (3). In Peng et al.’s review of SSEH treatment efficacy, 10 of 41 patients (24%) who were initially prescribed conservative management required surgical decompression due to clinical decline at an average of 7.5 days following symptom onset (14). Unfortunately, there was no further discussion on the final outcomes of this cohort. It would be interesting to compare this group of patients who underwent a trial of nonoperative management with those who underwent emergent/urgent surgical decompression for similar presenting symptoms. If they were to be similar, it would support initial trial of conservative measures in the absence of severe or progressive deficit. The relationship between coagulation status and its involvement with SSEH is not significantly correlated. In prior studies, presence of anticoagulation or coagulopathy was not shown to correlate with increased severity of presenting symptoms or serve as an independent risk factor for patient outcomes (3,10,14). Contrarily, there is data to show that the absence of anticoagulation/coagulopathy was associated with improved outcomes (14). Furthermore, patients who have their coagulopathy treated prior to or at the time of surgical intervention may have better odds of a favorable outcome (16). With increasing patient co-morbidity and use of anticoagulants, one would likely expect the incidence of symptomatic SSEH to increase. Given the generalized propensity for bleeding and larger hematoma formation in the setting of anticoagulant use, early recognition and prompt treatment of SSEH’s may be transformative in optimizing patient outcomes and avoiding potentially devastating neurologic injury. ITP in adults is diagnosed at a rate of 3.3 per 100,000 population per year (17). ES, which also involves autoimmune hemolytic anemia, plus or minus autoimmune neutropenia, is implicated in fewer than 5% of ITP cases. ITP results in the peripheral destruction of platelets, impaired platelet production by megakaryocytes, and altered platelet function (18). Treatment typically involves corticosteroids or immunomodulating drugs (4). In cases where pharmacotherapy fails, splenectomy may be required. Although a multitude of factors influence the propensity to bleed, patients with ITP are generally at increased risk of bleeding when platelet counts fall below 30,000/µL (19,20). The integument and oral and nasal mucosa are the most common sites of bleeding seen in ITP (21). Bleeding around the central nervous system, which includes intracranial as well as intraspinal bleeds, is exceedingly rare and accounts for less than 1% of spontaneous bleeding associated with ITP (22). In our review of the literature, only two case reports of ITP-associated SSEH were found. One case was managed conservatively, while the other consisted of surgical decompression and splenectomy. In both studies, good outcomes were reported following swift intervention (23,24). Similarly, in the anesthesia literature, there are several cases of thrombocytopenia associated with epidural hematoma following lumbar puncture/neuraxial anesthesia. Although there are guidelines with respect to platelet count, it is acknowledged that a single measurement of platelets alone may not fully predict the risk for clinically significant bleeding (25). There are several interesting points in the case at hand. As previously mentioned, the patient demonstrated preserved sensation and motor function. Although his inability to micturate could have been due to pain and prolonged supine positioning, sphincter dysfunction due to cord compression could not be ruled out. Given the fact that he had no true neurologic deficit, an argument could have been made to initiate conservative management and close observation with predisposition to proceed to the OR if his exam were to change. Regarding his thrombocytopenia, the patient reported that although he had seen a hematologist in the past, his condition was primarily being managed by his primary care provider. He noted that there were instances in which his platelet count had dropped from a baseline of approximately 20,000/µL to as low as 5,000/µL. In spite of this, he denied prior history of bleeding events. Ultimately, given the degree of stenosis seen on imaging, uncertainty of hematoma stability, and potential for cord compression resulting in neurologic deficit, a mutual decision was made to proceed with surgical intervention. A targeted decompression was performed. This reduced the risk of uncontrolled bony bleeding and need for a return to the OR for repeat decompression/hematoma evacuation. It also decreased the chance for future sagittal instability when compared to a long segment decompression. To date, the patient has demonstrated a good postoperative outcome with preserved motor, sensory and sphincter function. Given absence of symptoms, no further advanced imaging has been obtained to evaluate for hematoma resorption/residual hematoma. He currently receives rituximab infusions for ES treatment. Conclusions SSEH is a rare pathology that can result in catastrophic neurologic injury. The treatment of SSEH is often dependent upon patient presentation. In this case, where there was a concomitant blood dyscrasia and concern for impending neurologic insult, the patient was treated with surgical decompression and medical management of his underlying thrombocytopenia. To date, the patient has had an excellent outcome without change in baseline neurologic function or known major bleeding event. Supplementary The article’s supplementary files as Available at https://jss.amegroups.com/article/view/10.21037/jss-2026-1-0031/prf